Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Events Calendar
What's New
Explore
FAQs
Widgets
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Login / Sign up
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
Capacity Expansion
|
Expensive Performer
2714.1000
87.75
(
3.34
%)
NSE
Mar 21, 2025
15:31 PM
32.29% Gain from 52W Low
Volume:
1.1M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
20 May 2020
Capacity Expansion
2714.10
3.34%
Ajanta Pharma (BUY): Near-term growth concerns but demand outlook intact
Buy:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1650
BOB Capital Markets Ltd.
Ajanta Pharma (AJP) posted strong Q4 revenue/EBITDA growth of 32%/31% YoY to Rs 6.8bn/Rs 1.7bn.
Ajanta Pharma Ltd. is trading
above its 50 day SMA
of 2669.0
More from Ajanta Pharma Ltd.
Recommended
Five Interesting Stocks Today - March 21, 2025
The Baseline |
21 Mar 2025, 05:17PM
Market closes higher, CBI arrests Power Grid Corp's General Manager and KEC Intl's Deputy General Manager
Trendlyne Marketwatch |
21 Mar 2025, 04:10PM
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017